eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2021, Volume 17, Issue 1 : 14-17
Research Article
PCI Outcomes in Patients With Chronic Total Occlusion
 ,
 ,
1
Department of Interventional Cardiology, Global Heart Institute, Mumbai, India
2
Division of Cardiovascular Medicine, Royal Medical College, London, UK
3
Department of Clinical Research, Pacific Medical University, California, USA
Received
Feb. 18, 2021
Revised
April 29, 2021
Accepted
May 11, 2021
Published
June 21, 2021
Abstract

Chronic Total Occlusion (CTO) represents one of the most advanced manifestations of coronary artery disease (CAD) and is characterized by complete arterial blockage lasting more than three months. Percutaneous Coronary Intervention (PCI) for CTO has historically been associated with low success rates and higher complication risks, limiting its widespread adoption. Recent advancements such as hybrid antegrade-retrograde approaches, improved guidewires, and intravascular imaging have significantly improved procedural success and clinical outcomes. This study evaluates clinical, procedural, and long-term outcomes of PCI in CTO patients compared to conventional non-CTO PCI cases, focusing on mortality, myocardial infarction rates, left ventricular function, and symptom improvement. Results show that successful CTO PCI leads to substantial improvement in ventricular function, reduced angina, and lower hospitalization rates, although procedural complications remain higher than standard PCI.

 

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Personalized Healthcare Using Genomic Data: Advancing Precision Medicine Through Genomic Innovation
51-55
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Community-Based Health Programs and Their Effectiveness: Evaluating Impacts on Population Health Outcomes
13-19
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.